https://www.selleckchem.com/pe....ptide/angiotensin-ii
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3, by H.-Y. Cao, C.-H. Xiao, H.-J. Lu, H.-Z. Yu, H. Hong, C.-Y. Guo, J.-F. Yuan, published in Eur Rev Med Pharmacol Sci 2019; 23 (15) 6478-6485-DOI 10.26355/eurrev_201908_18531-PMID 31378887" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//w
Like
Comment
Share
